INSIDER
First dose of new Alzheimer’s drug administered by Michigan Institute for Neurological Disorders
Read full article: First dose of new Alzheimer’s drug administered by Michigan Institute for Neurological DisordersThe first dose of a new FDA-approved drug to treat Alzheimer’s disease was administered by the Michigan Institute of Neurological Disorders (MIND) on Wednesday.